Navigation Links
BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida
Date:9/12/2013

t was identified and treated on a particular day and time, as part of the BioClaim reporting functionality."  

About BioClaim, Inc.
BioClaim is a multi-patented biometric software platform that protects patients, providers and payers from fraudulent transactions while protecting the integrity of the electronic medical record. BioClaim creates a record of each patient visit which is transported like a virtual bridge from the provider's front desk to the payer in real time. The absence of the biometric template indicates a patient was not present on the date of services even though a bill was generated on their behalf. BioClaim is easily integrated with any electronic health record for accurate patient identification to guarantee entries and diagnosis to an electronic health systems are solely those that are attributed to the correct patient. BioClaim is truly the only solution that benefits payers, providers and patients. For more information, please visit www.BioClaim.com

About Amerigroup Florida
Amerigroup Florida has provided health care coverage in the state since 2003. We currently serve 251,000 members in the Medicaid, Children's Health Insurance Program (CHIP), Supplemental Security Income/Aged, Blind and Disabled (SSI/ABD), and Long-Term Care (LTC) programs in 61 counties in the Gulf, central and south Florida regions. We also offer Medicare Advantage plans in several counties. Our associates share genuine pride in making a difference in the lives of people who might need a little help. We are fortunate to call these combined efforts our work.

About SafeMatch® from Eye Controls
Eye Control's SafeMatch® Iris camera system has been in use since 2008 for positive patient registration and identification in Europe as well as across the US. SafeMatch® helps to reduce frau
'/>"/>

SOURCE BioClaim, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Leopoldina signs cooperation agreement with the Academy of Science of South Africa
2. Fluke Biomedical launches portable, feature-rich ProSim 3 and 2 Vital Signs Simulators
3. Light and nanoprobes detect early signs of infection
4. Encouraging signs for bee biodiversity
5. Early warning signs of population collapse
6. Shedding light on a gene mutation that causes signs of premature aging
7. Genetic signs of alcoholism in women studied for the first time
8. Streams show signs of degradation at earliest stages of urban development
9. Wiley signs collaboration agreement with the Asian Federation of Biotechnology
10. Brain scans detect early signs of autism
11. Children exposed to the common pollutant naphthalene show signs of chromosomal damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... land managers have a new synthesis of recent research ... (MMC) forests in the two states. , The ... Oregon and Washington: A Synthesis of the Relevant Biophysical ... technical report published by the U.S. Forest Service,s Pacific ... request from managers for a synthesis of the large ...
(Date:10/16/2014)... Northridge, Calif. (October 16, 2014) – Post-menopausal women ... effect on hormone levels or genital bleeding, after ... of an investigational fermented soy germ-based nutritional supplement ... according to a new peer-reviewed pilot study reported ... Society (NAMS) annual scientific meeting. , "These ...
(Date:10/15/2014)... is a non-traditional biophysics textbook and it describes how ... journey of discovery into biological systems and provides an ... It is about how our genes make proteins that ... of cells in an organism. It quantifies the principles ... can be found on both large and small scales. ...
Breaking Biology News(10 mins):New report synthesizes best available science on management of moist mixed-conifer forests 2S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2New book about life as seen from physics 2
... MIAMI African-American women with breast cancer living ... in treatment regardless of insurance type, socioeconomic status and ... A. Young, Ph.D., an associate professor of epidemiology at ... difficulties in measuring the impact of race and socioeconomic ...
... , BUFFALO, N.Y. -- Biomedical researchers at the University ... can grow continuously in culture, a discovery that could ... disease, diabetes, immune disorders and neurodegenerative diseases. , UB ... Universal" by genetically altering mesenchymal stem cells, which ...
... the past three decades, saturated fat has been considered a major ... persists in recommending reduced consumption of this macronutrient. However, new ... impact on CVD risk -- causing many to rethink the "saturated ... articles published in the October issue of Lipids ...
Cached Biology News:Racial differences in breast cancer treatment persist despite similar economics 2Researchers engineer adult stem cells that do not age 2Think saturated fat contributes to heart disease? Think again 2Think saturated fat contributes to heart disease? Think again 3
(Date:10/20/2014)... 2014 Convey Computer , the ... from Iowa State University won first place in the ... Convey HC-2ex, the team’s solution achieved the highest overall ... the second place finisher. , Experts from all segments ... month long challenge, using a variety of design tools, ...
(Date:10/20/2014)... , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... P. Horovitz , Ph.D., from its board of directors effective ... in August 2003, and served as its chairman from June ... on the Nominating and Corporate Governance and Audit Committees of ... more than a decade of dedicated service to GenVec, and ...
(Date:10/20/2014)... Local veterinary surgeon, Dr. Tim McCarthy is ... donor stem cells for dogs with osteoarthritis. Dr. McCarthy ... performed clinical stem cell therapy for 7 years. The ... a single injection of donor stem cells into one ... and inflammation in the treated joints. , Candidates ...
(Date:10/19/2014)... 2014 The Asia-Pacific Bromine Market ... Asia-Pacific with analysis and forecast of revenue. , ... Bromine Market report, to get an idea of ... glimpse of the segmentation in the Asia-Pacific bromine ... figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , Bromine ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3Zola P. Horovitz To Retire From GenVec Board 2Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3
... Feb. 3 .decimal, Inc. announced today that,it ... Inc. to supply,patient-specific devices for its proton therapy ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO ) , ... have a formal agreement signed with ProCure to ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) ... randomized, double-blind, placebo-controlled clinical study of 6R-BH4 in ... There was no statistical significance observed between the ... the study, peak walking time (PWT), did not ...
... Feb. 3 Cardium Therapeutics,(NYSE: CXM ) ... New,England Journal of Medicine showing the long-term outcome of ... a fatal disorder of the immune system.,The infant children ... SCID arises in infants with a genetic defect ...
Cached Biology Technology:ProCure Signs Agreement with .decimal, Inc. to Purchase Patient-Specific Devices for Its Proton Therapy Center in Oklahoma City 2Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant 2Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant 3Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant 4Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine 2Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine 3Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine 4Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine 5
... /K + ATPase α-1, clone C464.6 ... Immunogen : Purified Na + /K + ... rabbit kidney outer medulla Formulation: 0.1M Tris-glycine, ... azide Quality Assurance: routinely evaluated in immunoblot ...
Purified anti-mouse Tim-1...
Mouse Anti-human CD11b/Mac-1alpha, clone LM2/1, Monoclonal Antibody...
... The epitope is specific for Kir2.1 ... other known protein.,SPECIES REACTIVITIES: The ... bovine, porcine and guinea pig. It ... mouse (17/19 residues) and chick (15/19 ...
Biology Products: